Plain-English translation of NCT06888128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing psilocybin, a naturally occurring compound, combined with professional counseling to treat PTSD in US military veterans. Researchers will measure whether the medication is safe, well-tolerated, and actually helps reduce trauma symptoms. The trial builds on earlier research that showed promising results with this combination approach.
Many veterans struggle with PTSD even after trying standard treatments like antidepressants or talk therapy alone. This trial exists to see if this medication, used alongside guided therapy in a controlled setting, might offer a new pathway to healing for those whose symptoms haven't improved with conventional options.
You likely qualify if…
You likely don't qualify if…
You would participate in a 5-week program that includes 3 preparation sessions with a therapist to get ready, 2 supervised days where you receive the medication in a safe clinical setting, and 4 follow-up integration sessions to process your experience and help anchor the benefits. Throughout, trained clinicians will monitor your safety and wellbeing.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States